BR100 Decreased By (-0.07%)
BR30 Decreased By (-0.07%)
KSE100 Decreased By (-0.14%)
KSE30 Decreased By (-0.2%)
AGHA 7.73 Decreased By ▼ -0.08 (-1.02%)
BECO 5.19 Decreased By ▼ -0.02 (-0.38%)
BML 57.50 No Change ▼ 0.00 (0%)
BOP 33.89 Decreased By ▼ -0.14 (-0.41%)
CNERGY 10.00 Increased By ▲ 0.04 (0.4%)
CSIL 5.35 Increased By ▲ 0.04 (0.75%)
FCCL 54.50 Decreased By ▼ -0.20 (-0.37%)
FFL 16.75 Increased By ▲ 0.06 (0.36%)
FNEL 1.25 Increased By ▲ 0.02 (1.63%)
KEL 7.38 Decreased By ▼ -0.02 (-0.27%)
KOSM 5.70 Decreased By ▼ -0.07 (-1.21%)
LOTCHEM 29.23 Decreased By ▼ -0.09 (-0.31%)
MLCF 93.75 Decreased By ▼ -0.61 (-0.65%)
NBP 202.83 Decreased By ▼ -0.22 (-0.11%)
NCPL 57.00 No Change ▼ 0.00 (0%)
NPL 67.60 Decreased By ▼ -0.10 (-0.15%)
OGDC 316.70 Increased By ▲ 0.86 (0.27%)
PACE 10.68 Increased By ▲ 0.04 (0.38%)
PAEL 43.03 Decreased By ▼ -0.17 (-0.39%)
PIBTL 16.70 Decreased By ▼ -0.04 (-0.24%)
PPL 219.29 Decreased By ▼ -0.49 (-0.22%)
PRL 49.85 Increased By ▲ 0.66 (1.34%)
PTC 70.91 Increased By ▲ 0.38 (0.54%)
SSGC 27.93 Decreased By ▼ -0.32 (-1.13%)
TBL 9.83 Decreased By ▼ -0.03 (-0.3%)
TELE 8.79 No Change ▼ 0.00 (0%)
TPL 18.24 No Change ▼ 0.00 (0%)
TPLP 13.49 Increased By ▲ 0.22 (1.66%)
TREET 22.50 Decreased By ▼ -0.22 (-0.97%)
TRG 60.25 Increased By ▲ 0.11 (0.18%)
Pakistan

China's CanSinoBIO COVID-19 vaccine approved for emergency use in Pakistan

  • The approval was granted by the authority’s registration board on Friday.
  • Pakistan is the second country to approve use of China’s vaccine after Mexico.
Published Updated

The Drug Regulatory Authority of Pakistan (DRAP) has approved the emergency use of Chinese coronavirus (COVID-19) vaccine from CanSino Biologics.

As per details, the approval was granted by the authority’s registration board on Friday.

A request for the approval of the drug for emergency use was submitted to DRAP's registration board by AJM Pharma (Pvt) Limited, the report said.

The decision to approve it was taken during the third meeting of the authority's registration board.

Pakistan is the second country to approve use of China’s vaccine after Mexico.

Clinical trials for CanSinoBIO's vaccine were already going on in several countries, including Pakistan.

Comments

Comments are closed for this article.